Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VANIVivani Medical, Inc.

Nasdaq · CIK 0001266806
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3845 Electromedical & Electrotherapeutic Apparatus
FY end1231
XBRL facts382

Identity from submissions API

NameVivani Medical, Inc.
CIK0001266806
TickersVANI
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3845 Electromedical & Electrotherapeutic Apparatus
EIN020692322
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone415-506-8462
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • SECOND SIGHT MEDICAL PRODUCTS INC (2006-05-02T00:00:00.000Z → 2022-08-18T00:00:00.000Z)
  • SECOUND SIGHT MEDICAL PRODUCTS INC (2003-10-10T00:00:00.000Z → 2003-10-10T00:00:00.000Z)
Business address
1350 S. LOOP ROAD
ALAMEDA
CA
94502
CA
Mailing address
1350 S. LOOP ROAD
ALAMEDA
CA
94502
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

846 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 PRIMARY DOCUMENT 0001753926-26-002210 8907
2026-11-19 4 PRIMARY DOCUMENT 0001753926-26-002205 7131
2026-11-18 4 PRIMARY DOCUMENT 0001753926-26-002195 8373
2026-11-16 8-K 8-K 1.01,3.02,7.01,9.01 0001753926-26-002153 001-36747 261561765 34 15338093 1 1
2026-11-16 4 PRIMARY DOCUMENT 0001753926-26-002141 6692
2026-11-13 4 PRIMARY DOCUMENT 0001753926-26-002139 6939
2026-11-12 8-K 8-K 2.02,7.01,8.01,9.01 0001753926-26-002108 001-36747 261543599 34 11602910 1 1
2026-11-12 10-Q 10-Q 0001753926-26-002106 001-36747 261543430 34 7832377 1 1
2026-10-30 8-K 8-K 7.01 0001753926-26-002036 001-36747 261508434 34 212787 1 1
2026-10-29 8-K 8-K 7.01,9.01 0001753926-26-002024 001-36747 261497510 34 11366793 1 1
2026-10-19 4 PRIMARY DOCUMENT 0001753926-26-001963 6374
2026-09-25 424B5 424B5 0001753926-26-001863 333-278869 261411276 33 411582
2026-09-16 8-K 8-K 7.01 0001753926-26-001808 001-36747 261383902 34 212505 1 1
2026-08-17 8-K 8-K 7.01,9.01 0001753926-26-001536 001-36747 261284852 34 10858217 1 1
2026-08-13 8-K 8-K 2.02,7.01,9.01 0001753926-26-001482 001-36747 261274076 34 11920167 1 1
2026-08-13 10-Q 10-Q 0001753926-26-001477 001-36747 261273040 34 7741877 1 1
2026-08-06 8-K 8-K 7.01,9.01 0001753926-26-001349 001-36747 261246196 34 239737 1 1
2026-07-30 4 PRIMARY DOCUMENT 0001753926-26-001286 28497
2026-07-30 4 PRIMARY DOCUMENT 0001753926-26-001285 20752
2026-07-30 4 PRIMARY DOCUMENT 0001753926-26-001284 29539
2026-07-30 4 PRIMARY DOCUMENT 0001753926-26-001283 20774
2026-07-30 4 PRIMARY DOCUMENT 0001753926-26-001282 27099
2026-07-28 4 PRIMARY DOCUMENT 0001753926-26-001243 5892
2026-07-16 4 PRIMARY DOCUMENT 0001753926-26-001192 6810
2026-07-16 8-K 8-K 7.01,9.01 0001753926-26-001190 001-36747 261178746 34 7177542 1 1
2026-07-07 8-K 8-K 1.01,8.01,9.01 0001753926-26-001144 001-36747 261157826 34 3471842 1 1
2026-06-30 8-K 8-K 5.02,5.07,8.01,9.01 0001753926-26-001109 001-36747 261138058 34 595443 1 1
2026-06-26 4 PRIMARY DOCUMENT 0001753926-26-001081 5838
2026-06-26 3 PRIMARY DOCUMENT 0001753926-26-001078 25561
2026-06-25 4 PRIMARY DOCUMENT 0001753926-26-001072 5865
2026-06-25 4 PRIMARY DOCUMENT 0001753926-26-001070 5982
2026-06-25 4 PRIMARY DOCUMENT 0001753926-26-001069 5910
2026-06-25 4 PRIMARY DOCUMENT 0001753926-26-001066 5870
2026-06-16 4 PRIMARY DOCUMENT 0001753926-26-001014 6815
2026-06-04 8-K 8-K 7.01,9.01 0001753926-26-000974 001-36747 261063212 34 10210829 1 1
2026-05-19 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753926-26-000912 005-88691 26996960 34 18107
2026-05-19 4 PRIMARY DOCUMENT 0001753926-26-000910 6743
2026-05-13 8-K 8-K 2.02,7.01,9.01 0001753926-26-000854 001-36747 26973784 34 339617 1 1
2026-05-13 10-Q 10-Q 0001753926-26-000852 001-36747 26973765 34 7156606 1 1
2026-04-29 ARS ARS 0001753926-26-000752 001-36747 26916848 34 2508414
2026-04-29 DEFA14A DEFA 14A 0001753926-26-000751 001-36747 26916782 34 1239729
2026-04-29 DEF 14A DEF14A 0001753926-26-000750 001-36747 26916730 34 4125295 1 1
2026-04-16 4 PRIMARY DOCUMENT 0001753926-26-000672 6743
2026-03-26 8-K 8-K 2.02,9.01 0001753926-26-000550 001-36747 26798813 34 350429 1 1
2026-03-26 10-K 10-K 0001753926-26-000548 001-36747 26798765 34 13879157 1 1
2026-03-16 4 PRIMARY DOCUMENT 0001753926-26-000475 9089
2026-02-17 4 PRIMARY DOCUMENT 0001753926-26-000323 9091
2026-01-28 4 PRIMARY DOCUMENT 0001753926-26-000196 6681
2026-01-27 8-K 8-K 1.01,3.02,7.01,9.01 0001753926-26-000194 001-36747 26565602 34 1419406 1 1
2026-01-27 424B5 424B5 0001753926-26-000186 333-278869 26561965 33 751690
2026-01-20 4 PRIMARY DOCUMENT 0001753926-26-000145 9092
2026-01-05 4 PRIMARY DOCUMENT 0001753926-26-000045 5701
2026-01-05 4 PRIMARY DOCUMENT 0001753926-26-000044 5658
2025-12-31 4 PRIMARY DOCUMENT 0001753926-25-002003 8516
2025-12-16 4 PRIMARY DOCUMENT 0001753926-25-001892 9094
2025-11-17 4 PRIMARY DOCUMENT 0001753926-25-001808 9094
2025-11-13 10-Q 10-Q 0001753926-25-001770 001-36747 251475536 34 8094064 1 1
2025-11-13 8-K 8-K 2.02,7.01,9.01 0001753926-25-001768 001-36747 251475483 34 4048679 1 1
2025-10-28 4 PRIMARY DOCUMENT 0001753926-25-001658 6633
2025-10-28 8-K 8-K 1.01,3.02,7.01,9.01 0001753926-25-001655 001-36747 251421182 34 1375175 1 1
2025-10-28 424B5 424B5 0001753926-25-001653 333-278869 251421162 33 665290
2025-10-16 4 PRIMARY DOCUMENT 0001753926-25-001616 9078
2025-10-03 8-K 8-K 7.01,8.01,9.01 0001753926-25-001582 001-36747 251372154 34 244425 1 1
2025-09-17 4 PRIMARY DOCUMENT 0001753926-25-001511 9078
2025-09-17 8-K 8-K 8.01,9.01 0001753926-25-001510 001-36747 251318924 34 280887 1 1
2025-09-09 8-K 8-K 7.01,9.01 0001753926-25-001443 001-36747 251303503 34 4079508 1 1
2025-09-04 8-K 8-K 8.01,9.01 0001753926-25-001431 001-36747 251294121 34 264015 1 1
2025-08-13 10-Q 10-Q 0001753926-25-001330 001-36747 251212664 34 7639178 1 1
2025-08-13 8-K 8-K 1.01,2.02,3.02,7.01,8.01,9.01 0001753926-25-001328 001-36747 251212541 34 55356471 1 1
2025-08-05 8-K 8-K 2.02,7.01,8.01,9.01 0001753926-25-001228 001-36747 251182929 34 481988 1 1
2025-06-26 4 PRIMARY DOCUMENT 0001753926-25-001037 21162
2025-06-26 4 PRIMARY DOCUMENT 0001753926-25-001031 19731
2025-06-26 4 PRIMARY DOCUMENT 0001753926-25-001029 21405
2025-06-26 4 PRIMARY DOCUMENT 0001753926-25-001027 24092
2025-06-26 4 PRIMARY DOCUMENT 0001753926-25-001024 20927
2025-06-25 8-K 8-K 5.07 0001753926-25-001005 001-36747 251073957 34 233273 1 1
2025-06-17 4 PRIMARY DOCUMENT 0001753926-25-000972 5564
2025-06-17 3 PRIMARY DOCUMENT 0001753926-25-000971 18670
2025-06-17 8-K 8-K 7.01,9.01 0001753926-25-000966 001-36747 251051779 34 7332462 1 1
2025-06-11 8-K 8-K 5.02,7.01,9.01 0001753926-25-000956 001-36747 251038852 34 267556 1 1
2025-05-29 8-K 8-K 8.01,9.01 0001753926-25-000898 001-36747 25997875 34 273944 1 1
2025-05-16 4 PRIMARY DOCUMENT 0001753926-25-000860 9233
2025-05-14 4 PRIMARY DOCUMENT 0001753926-25-000831 8394
2025-05-14 4 PRIMARY DOCUMENT 0001753926-25-000828 8392
2025-05-14 4 PRIMARY DOCUMENT 0001753926-25-000826 8389
2025-05-14 4 PRIMARY DOCUMENT 0001753926-25-000824 8401
2025-05-14 4 PRIMARY DOCUMENT 0001753926-25-000822 8415
2025-05-13 10-Q 10-Q 0001753926-25-000794 001-36747 25940960 34 6771833 1 1
2025-05-13 8-K 8-K 1.01,2.02,3.02,7.01,8.01,9.01 0001753926-25-000792 001-36747 25940875 34 3141922 1 1
2025-05-06 DEFR14A DEFR14A 0001753926-25-000746 001-36747 25917374 34 2307370 1 1
2025-04-29 ARS ARS 0001753926-25-000698 001-36747 25882775 34 4012660
2025-04-29 DEFA14A DEFA14A 0001753926-25-000696 001-36747 25882769 34 296973
2025-04-29 DEF 14A DEF 14A 0001753926-25-000694 001-36747 25882757 34 2283177 1 1
2025-04-28 4 PRIMARY DOCUMENT 0001554855-25-000391 5869
2025-04-23 4 PRIMARY DOCUMENT 0001753926-25-000675 7534
2025-04-15 8-K 8-K 8.01,9.01 0001753926-25-000635 001-36747 25837717 34 253238 1 1
2025-04-11 4 PRIMARY DOCUMENT 0001753926-25-000620 7536
2025-04-08 4 PRIMARY DOCUMENT 0001753926-25-000596 12224
2025-04-04 4 PRIMARY DOCUMENT 0001753926-25-000583 7939
2025-04-01 4 PRIMARY DOCUMENT 0001753926-25-000555 4725
2025-03-31 10-K 10-K 0001753926-25-000527 001-36747 25789123 34 11747079 1 1
2025-03-31 8-K 8-K 2.02,7.01,9.01 0001753926-25-000526 001-36747 25789106 34 2500810 1 1
2025-03-27 8-K 8-K 1.01,3.02,8.01,9.01 0001753926-25-000495 001-36747 25775651 34 498279 1 1
2025-03-26 8-K 8-K 8.01,9.01 0001753926-25-000488 001-36747 25770206 34 275280 1 1
2025-03-13 8-K 8-K 2.02,7.01,8.01,9.01 0001753926-25-000438 001-36747 25733851 34 336552 1 1
2025-03-03 4 PRIMARY DOCUMENT 0001753926-25-000392 4731
2025-01-03 4 PRIMARY DOCUMENT 0001753926-25-000017 5677
2025-01-03 4 PRIMARY DOCUMENT 0001753926-25-000016 5635
2024-11-13 4 PRIMARY DOCUMENT 0001753926-24-001875 6901
2024-11-13 10-Q 10-Q 0001753926-24-001874 001-36747 241451363 34 6487563 1 1
2024-11-13 8-K 8-K 2.02,7.01,9.01 0001753926-24-001872 001-36747 241451344 34 2379302 1 1
2024-10-22 8-K 8-K 8.01,9.01 0001753926-24-001731 001-36747 241384763 34 255726 1 1
2024-10-03 4 PRIMARY DOCUMENT 0001753926-24-001643 7741
2024-09-26 8-K 8-K 8.01,9.01 0001753926-24-001628 001-36747 241326252 34 265958 1 1
2024-09-23 8-K 8-K 8.01,9.01 0001753926-24-001614 001-36747 241314679 34 256642 1 1
2024-09-04 8-K 8-K 8.01,9.01 0001753926-24-001531 001-36747 241275935 34 289251 1 1
2024-08-13 8-K 8-K 2.02,7.01,9.01 0001753926-24-001422 001-36747 241202098 34 2332659 1 1
2024-08-13 10-Q 10-Q 0001753926-24-001420 001-36747 241201840 34 6188705 1 1
2024-08-01 4 PRIMARY DOCUMENT 0001753926-24-001335 6237
2024-08-01 4 PRIMARY DOCUMENT 0001753926-24-001334 4732
2024-07-11 8-K 8-K 8.01,9.01 0001753926-24-001236 001-36747 241111078 34 227468 1 1
2024-07-01 4 xslF345X05/ownership.xml 0001753926-24-001197 16805
2024-07-01 4 xslF345X05/ownership.xml 0001753926-24-001195 16924
2024-07-01 4 xslF345X05/ownership.xml 0001753926-24-001193 5722
2024-07-01 4 xslF345X05/ownership.xml 0001753926-24-001191 16436
2024-07-01 4 xslF345X05/ownership.xml 0001753926-24-001189 16789
2024-06-28 8-K 8-K 5.07,9.01 0001753926-24-001171 001-36747 241085672 34 219618 1 1
2024-06-13 8-K 8-K 8.01,9.01 0001753926-24-001110 001-36747 241040043 34 224007 1 1
2024-05-14 4 xslF345X05/ownership.xml 0001753926-24-000968 19813
2024-05-14 4 xslF345X05/ownership.xml 0001753926-24-000967 19860
2024-05-14 4 xslF345X05/ownership.xml 0001753926-24-000966 19550
2024-05-14 4 xslF345X05/ownership.xml 0001753926-24-000965 19634
2024-05-14 4 xslF345X05/ownership.xml 0001753926-24-000964 19618
2024-05-13 10-Q 10-Q 0001753926-24-000959 001-36747 24940452 34 4310727 1 1
2024-05-13 8-K 8-K 2.02,7.01,9.01 0001753926-24-000957 001-36747 24939977 34 6879804 1 1
2024-05-03 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-03 16:00:00 9999999995-24-001376 333-278869 24915367 33 1853
2024-05-02 CORRESP filename1.htm 0001753926-24-000907 10764
2024-05-02 S-3/A S-3/A 0001753926-24-000905 333-278869 24909218 33 68462
2024-04-29 ARS ARS 0001753926-24-000868 001-36747 24891790 34 1224431
2024-04-29 DEFA14A DEFA14A 0001753926-24-000866 001-36747 24891541 34 493473
2024-04-29 DEF 14A DEF 14A 0001753926-24-000864 001-36747 24891396 34 4107949 1 1
2024-04-29 UPLOAD filename1.pdf 0000000000-24-004741 333-278869 40436
2024-04-23 8-K 8-K 1.01,9.01 0001753926-24-000816 001-36747 24862199 34 209261 1 1
2024-04-22 S-3 S-3 0001753926-24-000814 333-278869 24862150 33 1802010
2024-03-29 4 xslF345X05/ownership.xml 0001753926-24-000644 5689
2024-03-27 4 xslF345X05/ownership.xml 0001753926-24-000622 16415
2024-03-26 10-K 10-K 0001753926-24-000616 001-36747 24783449 34 14082061 1 1
2024-03-26 8-K 8-K 2.02,7.01,9.01 0001753926-24-000612 001-36747 24781030 34 8008453 1 1
2024-03-11 3 xslF345X02/ownership.xml 0001753926-24-000512 6112
2024-03-06 8-K 8-K 5.02,9.01 0001753926-24-000474 001-36747 24724440 34 228824 1 1
2024-03-05 8-K 8-K 1.01,7.01,9.01 0001753926-24-000466 001-36747 24720780 34 768417 1 1
2024-03-05 424B5 424B5 0001753926-24-000463 333-256904 24718960 33 842118
2024-03-05 144 xsl144X01/primary_doc.xml 0001959173-24-001867 001-36747 24718419 33 5934
2024-02-28 8-K 8-K 7.01,9.01 0001753926-24-000411 001-36747 24690412 34 10328571 1 1
2024-02-20 4 xslF345X05/ownership.xml 0001753926-24-000345 6426
2024-02-09 4 xslF345X05/ownership.xml 0001753926-24-000261 7943
2024-02-06 4 xslF345X05/ownership.xml 0001753926-24-000224 7941
2024-02-02 4 xslF345X05/ownership.xml 0001753926-24-000210 6425
2024-01-25 4 xslF345X05/ownership.xml 0001753926-24-000164 6425
2024-01-22 4 xslF345X05/ownership.xml 0001753926-24-000131 6426
2024-01-19 4 xslF345X05/ownership.xml 0001753926-24-000128 7940
2024-01-16 4 xslF345X05/ownership.xml 0001753926-24-000109 6427
2024-01-10 8-K 8-K 8.01,9.01 0001753926-24-000087 001-36747 24526925 34 203104 1 1
2024-01-09 4 xslF345X05/ownership.xml 0001753926-24-000081 6426
2024-01-05 4 xslF345X05/ownership.xml 0001753926-24-000066 7943
2024-01-03 4 xslF345X05/ownership.xml 0001753926-24-000055 7943
2023-12-27 4 xslF345X05/ownership.xml 0001753926-23-001648 6426
2023-12-27 8-K 8-K 3.01,9.01 0001753926-23-001644 001-36747 231518781 34 206165 1 1
2023-12-21 4 xslF345X05/ownership.xml 0001753926-23-001621 9462
2023-12-18 4 xslF345X05/ownership.xml 0001753926-23-001595 9460
2023-12-18 4 xslF345X05/ownership.xml 0001753926-23-001593 6612
2023-12-13 4 xslF345X05/ownership.xml 0001753926-23-001576 7838
2023-12-08 4 xslF345X05/ownership.xml 0001753926-23-001571 6321
2023-11-27 4 xslF345X05/ownership.xml 0001753926-23-001541 7837
2023-11-24 8-K 8-K 5.02,9.01 0001753926-23-001534 001-36747 231436378 34 210127 1 1
2023-11-22 4 xslF345X05/ownership.xml 0001753926-23-001531 7656
2023-11-20 4 xslF345X05/ownership.xml 0001753926-23-001511 7838
2023-11-14 8-K 8-K 2.02,7.01,9.01 0001753926-23-001482 001-36747 231401357 34 7766190 1 1
2023-11-13 10-Q FORM 10-Q 0001753926-23-001474 001-36747 231399361 34 4006214 1 1
2023-10-24 4 xslF345X05/ownership.xml 0001753926-23-001382 9357
2023-10-16 4 xslF345X05/ownership.xml 0001753926-23-001344 9355
2023-10-11 4 xslF345X05/ownership.xml 0001753926-23-001316 6320
2023-10-10 4 xslF345X05/ownership.xml 0001753926-23-001314 6322
2023-10-05 4 xslF345X05/ownership.xml 0001753926-23-001304 9355
2023-10-02 4 xslF345X05/ownership.xml 0001753926-23-001285 7840
2023-09-27 4 xslF345X05/ownership.xml 0001753926-23-001275 4664
2023-09-27 4 xslF345X05/ownership.xml 0001753926-23-001273 9397
2023-09-22 4 xslF345X05/ownership.xml 0001753926-23-001254 7879
2023-09-18 4 xslF345X05/ownership.xml 0001753926-23-001243 7881
2023-09-18 8-K 8-K 7.01,9.01 0001753926-23-001239 001-36747 231260069 34 2394469 1 1
2023-09-12 4 xslF345X05/ownership.xml 0001753926-23-001215 9393
2023-09-07 4 xslF345X05/ownership.xml 0001753926-23-001198 9395
2023-09-05 4 xslF345X05/ownership.xml 0001753926-23-001192 4665
2023-09-05 4 xslF345X05/ownership.xml 0001753926-23-001190 6513
2023-09-01 4 xslF345X05/ownership.xml 0001753926-23-001183 7877
2023-08-29 8-K FORM 8-K 1.01,7.01,9.01 0001753926-23-001153 001-36747 231217402 34 6531513 1 1
2023-08-18 4 xslF345X05/ownership.xml 0001753926-23-001082 4664
2023-08-14 10-Q FORM 10Q 0001753926-23-001062 001-36747 231170949 34 4018022 1 1
2023-07-10 8-K 8-K 3.03,5.03,8.01,9.01 0001753926-23-000914 001-36747 231079774 34 2027111 1 1
2023-06-29 4 xslF345X04/ownership.xml 0001753926-23-000869 6554
2023-06-26 4 xslF345X04/ownership.xml 0001753926-23-000850 4665
2023-06-20 4 FORM 4 0001753926-23-000817 5456
2023-06-20 4 FORM 4 0001753926-23-000815 5443
2023-06-20 4 FORM 4 0001753926-23-000813 5466
2023-06-20 4 FORM 4 0001753926-23-000811 5441
2023-06-16 8-K 8-K 5.07,9.01 0001753926-23-000806 001-36747 231019302 34 246331 1 1
2023-06-12 4 FORM 4 0001753926-23-000794 4709
2023-05-15 8-K 8-K 2.02,7.01,9.01 0001753926-23-000657 001-36747 23918296 34 6461091 1 1
2023-05-15 10-Q FORM 10Q 0001753926-23-000655 001-36747 23918294 34 3450922 1 1
2023-05-02 SC 13D/A SC 13D/A 0001753926-23-000565 005-88691 23876164 34 70315
2023-05-01 4 xslF345X04/ownership.xml 0001753926-23-000563 7137
2023-05-01 ARS/A ARS/A 0001753926-23-000561 001-36747 23874695 34 9137940
2023-05-01 DEFR14A DEFR14A 0001753926-23-000559 001-36747 23874574 34 6008798 1 1
2023-04-28 ARS ARS 0001753926-23-000529 001-36747 23861966 34 1066633
2023-04-28 DEFA14A g083506_defa14a.htm 0001753926-23-000527 001-36747 23861938 34 745495
2023-04-28 DEF 14A DEF 14A 0001753926-23-000525 001-36747 23861898 34 6007431 1 1
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000518 7123
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000516 8036
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000514 10409
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000512 11316
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000510 6213
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000508 8034
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000506 8033
2023-04-25 4 xslF345X04/ownership.xml 0001753926-23-000504 7124
2023-04-25 3 xslF345X02/ownership.xml 0001753926-23-000502 5299
2023-04-25 SC 13D SC 13D 0001753926-23-000500 005-88691 23845986 34 49730
2023-04-19 4 xslF345X04/ownership.xml 0001753926-23-000483 6187
2023-04-19 PRE 14A PRE 14A 0001753926-23-000475 001-36747 23828380 34 3506711
2023-03-31 10-K 10-K 0001753926-23-000344 001-36747 23786289 34 6491563 1 1
2023-03-21 8-K 8-K 1.01,7.01,9.01 0001753926-23-000298 001-36747 23749744 34 3384770 1 1
2023-03-08 4 xslF345X03/ownership.xml 0001753926-23-000267 7817
2023-03-08 4 xslF345X03/ownership.xml 0001753926-23-000265 5638
2023-03-08 4 xslF345X03/ownership.xml 0001753926-23-000263 7826
2023-03-08 4 xslF345X03/ownership.xml 0001753926-23-000261 7795
2023-03-08 4 xslF345X03/ownership.xml 0001753926-23-000259 8132
2023-02-17 8-K 8-K 7.01,9.01 0001753926-23-000173 001-36747 23640202 34 2330429 1 1
2023-02-10 4 xslF345X03/ownership.xml 0001753926-23-000124 4647
2023-01-23 4 xslF345X03/ownership.xml 0001753926-23-000082 5344
2023-01-23 4 xslF345X03/ownership.xml 0001753926-23-000080 7518
2023-01-23 4 xslF345X03/ownership.xml 0001753926-23-000078 7497
2023-01-23 4 xslF345X03/ownership.xml 0001753926-23-000076 7506
2023-01-23 4 xslF345X03/ownership.xml 0001753926-23-000074 5308
2023-01-06 8-K 8-K 7.01,9.01 0001753926-23-000030 001-36747 23515071 34 3156269 1 1
2022-12-15 8-K 8-K 8.01,9.01 0001753926-22-001590 001-36747 221465385 34 206796 1 1
2022-11-28 8-K 8-K 1.01,9.01 0001753926-22-001508 001-36747 221427161 34 1469847 1 1
2022-11-21 4 xslF345X03/ownership.xml 0001753926-22-001490 6147
2022-11-14 10-Q 10-Q 0001753926-22-001464 001-36747 221385750 34 3505802 1 1
2022-11-14 8-K 8-K 2.02,7.01,9.01 0001753926-22-001463 001-36747 221385518 34 278454 1 1
2022-11-09 4 xslF345X03/ownership.xml 0001753926-22-001443 5433
2022-11-09 4 xslF345X03/ownership.xml 0001753926-22-001441 5521
2022-10-17 8-K 8-K 7.01,8.01,9.01 0001753926-22-001382 001-36747 221312522 34 2340225 1 1
2022-09-23 8-K 8-K 7.01,9.01 0001753926-22-001291 001-36747 221260535 34 2740419 1 1
2022-09-16 4 xslF345X03/ownership.xml 0001753926-22-001278 5505
2022-09-16 4 xslF345X03/ownership.xml 0001753926-22-001276 5404
2022-09-08 25 25 0001753926-22-001240 001-36747 221234435 34 28106
2022-09-02 S-8 S-8 0001753926-22-001227 333-267271 221225952 33 316114
2022-09-02 8-K 8-K 1.01,2.01,5.01,5.02,5.03,7.01,9.01 0001753926-22-001222 001-36747 221224889 34 2977496 1 1
2022-09-02 SC 13D/A SC 13D/A 0001753926-22-001214 005-88691 221223095 34 78944
2022-09-01 4 xslF345X03/ownership.xml 0001753926-22-001212 10153
2022-09-01 4 xslF345X03/ownership.xml 0001753926-22-001210 71577
2022-09-01 SC 13D SC 13D 0001753926-22-001198 005-88691 221219128 34 43745
2022-08-31 4 xslF345X03/ownership.xml 0001753926-22-001202 11467
2022-08-31 4 xslF345X03/ownership.xml 0001753926-22-001200 18577
2022-08-31 4 xslF345X03/ownership.xml 0001753926-22-001196 14334
2022-08-31 3 xslF345X02/ownership.xml 0001753926-22-001194 3509
2022-08-31 4 xslF345X03/ownership.xml 0001753926-22-001192 8245
2022-08-31 3 xslF345X02/ownership.xml 0001753926-22-001190 3492
2022-08-31 3 xslF345X02/ownership.xml 0001753926-22-001188 3504
2022-08-31 4 xslF345X03/ownership.xml 0001753926-22-001184 10011
2022-08-31 3 xslF345X02/ownership.xml 0001753926-22-001182 3526
2022-08-31 4 xslF345X03/ownership.xml 0001753926-22-001180 5786
2022-08-31 3 xslF345X02/ownership.xml 0001753926-22-001178 3535
2022-08-18 8-K 8-K 5.03,7.01,9.01 0001753926-22-001088 001-36747 221178184 34 290929 1 1
2022-08-12 10-Q 10-Q 0001753926-22-001055 001-36747 221157383 34 3196893 1 1
2022-08-05 8-K 8-K 5.02,9.01 0001753926-22-001017 001-36747 221140687 34 254180 1 1
2022-07-29 425 425 0001753926-22-000982 001-36747 221117706 34 135267
2022-07-29 8-K 8-K 5.07,8.01,9.01 0001753926-22-000981 001-36747 221117691 34 370792 1 1
2022-07-22 SC 13D/A SC 13D/A 0001753926-22-000957 005-88691 221100482 34 79786
2022-07-18 DEFA14A DEFA14A 0001753926-22-000924 001-36747 221088359 34 322558
2022-07-18 DEFA14A DEFA14A 0001753926-22-000922 001-36747 221088355 34 27060
2022-07-18 425 425 0001753926-22-000920 001-36747 221088352 34 37398
2022-07-18 8-K 8-K 8.01,9.01 0001753926-22-000919 001-36747 221088350 34 263114 1 1
2022-07-12 DEFA14A DEFA14A 0001753926-22-000906 001-36747 221078149 34 246030
2022-06-24 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2022-06-24 16:00:00 9999999995-22-001879 333-264959 221041480 33 1698
2022-06-24 DEFM14A DEFM14A 0001104659-22-074352 001-36747 221040680 34 12856077
2022-06-24 424B3 424B3 0001104659-22-074349 333-264959 221040625 33 8287787
2022-06-22 CORRESP filename1.htm 0001753926-22-000883 13275
2022-06-21 425 8-K 0001753926-22-000881 001-36747 221028114 34 42809
2022-06-21 8-K 8-K 1.01,9.01 0001753926-22-000879 001-36747 221028096 34 266731 1 1
2022-06-16 S-4/A FORM S-4/A 0001104659-22-071980 333-264959 221021533 33 18640366 1 1
2022-06-16 8-K 8-K 5.02,9.01 0001753926-22-000875 001-36747 221020524 34 250593 1 1
2022-06-15 4 xslF345X03/ownership.xml 0001753926-22-000873 8446
2022-06-07 4 xslF345X03/ownership.xml 0001753926-22-000855 6107
2022-06-07 425 425 0001753926-22-000853 001-36747 221001246 34 54782
2022-06-07 8-K 8-K 8.01,9.01 0001753926-22-000852 001-36747 221001237 34 285260 1 1
2022-06-02 4 xslF345X03/ownership.xml 0001753926-22-000842 10656
2022-05-25 4 xslF345X03/ownership.xml 0001753926-22-000800 8379
2022-05-23 UPLOAD filename1.pdf 0000000000-22-005621 40163
2022-05-20 4 xslF345X03/ownership.xml 0001753926-22-000760 10660
2022-05-16 10-Q 10-Q 0001753926-22-000721 001-36747 22928682 34 3106717 1 1
2022-05-13 S-4 FORM S-4 0001104659-22-060457 333-264959 22923931 33 14307031 1 1
2022-05-02 10-K/A 10-K/A 0001753926-22-000631 001-36747 22882101 34 311309
2022-04-29 5 xslF345X03/ownership.xml 0001753926-22-000609 4755
2022-03-29 10-K 10-K 0001753926-22-000356 001-36747 22777219 34 5697674 1 1
2022-02-08 425 8-K 0001753926-22-000171 001-36747 22598801 34 6280163
2022-02-08 8-K 8-K 1.01,7.01,9.01 0001753926-22-000169 001-36747 22598790 34 6690077 1 1
2022-01-13 SC 13G/A SECOND SIGHT MEDICAL PRODUCTS, INC. 0000902664-22-000209 005-88691 22528171 34 74204
2021-11-12 10-Q 10-Q 0001753926-21-000697 001-36747 211403564 34 3978811 1 1
2021-08-13 10-Q 10-Q 0001753926-21-000363 001-36747 211172226 34 4167373 1 1
2021-08-04 8-K 8-K 8.01 0001753926-21-000287 001-36747 211145174 34 15229
2021-07-02 8-K 8-K 4.01,9.01 0001753926-21-000225 001-36747 211069427 34 75994
2021-06-28 SC 13G SECOND SIGHT MEDICAL PRODUCTS, INC. 0000902664-21-003290 005-88691 211050628 34 79321
2021-06-28 8-K 8-K 1.01,8.01,9.01 0001753926-21-000214 001-36747 211049661 34 412721
2021-06-23 424B5 424B5 0001753926-21-000205 333-256904 211037789 33 520927
2021-06-23 8-K 8-K 8.01,9.01 0001753926-21-000202 001-36747 211037324 34 69238
2021-06-22 424B5 424B5 0001753926-21-000199 333-256904 211036335 33 520372
2021-06-21 8-K 8-K 8.01 0001564590-21-033665 001-36747 211031903 34 27279
2021-06-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-06-14 16:00:00 9999999995-21-002340 333-256904 211016754 33 1726
2021-06-11 CORRESP filename1.htm 0001564590-21-032546 161911
2021-06-10 UPLOAD filename1.pdf 0000000000-21-007223 40211
2021-06-10 4 FORM 4 SUBMISSION 0001209191-21-039403 4558
2021-06-08 S-3 S-3 0001564590-21-032143 333-256904 211002782 33 827691
2021-06-04 8-K 8-K 8.01 0001564590-21-031665 001-36747 21994776 34 28679
2021-06-03 8-K 8-K 8.01 0001564590-21-031460 001-36747 21991129 34 24432
2021-06-01 8-K 8-K 5.07,8.01,9.01 0001564590-21-030925 001-36747 21982714 34 182804
2021-05-13 10-Q 10-Q 0001564590-21-027142 001-36747 21916709 34 4204020 1
2021-04-30 DEF 14A DEF 14A 0001564590-21-022614 001-36747 21879955 34 884743
2021-04-29 424B3 424B3 0001564590-21-021545 333-255267 21866798 33 233107
2021-04-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-28 16:00:00 9999999995-21-001610 333-255267 21866829 33 1725
2021-04-27 3 FORM 3 SUBMISSION 0001209191-21-028633 3449
2021-04-27 CORRESP filename1.htm 0001564590-21-020916 161449
2021-04-27 10-K/A 10-K/A 0001564590-21-020872 001-36747 21858800 34 554961
2021-04-22 3 FORM 3 SUBMISSION 0001209191-21-027949 3464
2021-04-22 UPLOAD filename1.pdf 0000000000-21-005030 40228
2021-04-16 S-3 S-3 0001564590-21-019062 333-255267 21829644 33 473584
2021-04-14 10-K/A 10-K/A 0001564590-21-018750 001-36747 21824265 34 150310
2021-04-08 3 FORM 3 SUBMISSION 0001209191-21-026117 14469
2021-04-08 8-K 8-K 8.01 0001564590-21-018054 001-36747 21813298 34 24868
2021-04-07 D xslFormDX01/primary_doc.xml 06b 0001209191-21-025753 021-394867 21810349 33 10687
2021-04-06 8-K 8-K 5.02,8.01,9.01 0001564590-21-017685 001-36747 21808077 34 113582
2021-04-05 8-K 8-K 1.02,8.01 0001564590-21-017519 001-36747 21803925 34 25967
2021-04-01 8-K 8-K 5.02,8.01,9.01 0001564590-21-017170 001-36747 21795876 34 105773
2021-03-26 8-K 8-K 1.01,3.02,7.01,9.01 0001564590-21-015832 001-36747 21777781 34 870753
2021-03-24 8-K 8-K 7.01,8.01,9.01 0001564590-21-014948 001-36747 21766494 34 138112
2021-03-24 DEFA14A 8-K 0001564590-21-014949 001-36747 21766489 34 137958
2021-03-16 10-K 10-K 0001564590-21-013636 001-36747 21747000 34 8875119 1
2021-03-05 8-K/A 8-K/A 8.01,9.01 0001564590-21-011183 001-36747 21717722 34 73714
2021-03-05 DEFA14A 8-K/A 0001564590-21-011184 001-36747 21717713 34 73598
2021-03-05 8-K 8-K 8.01,9.01 0001564590-21-011108 001-36747 21716591 34 72254
2021-02-11 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-21-002102 005-88691 21619646 34 93642
2021-01-27 8-K 8-K 1.01,8.01,9.01 0001564590-21-002455 001-36747 21556624 34 163631
2021-01-20 SC 13G/A SECOND SIGHT MEDICAL PRODUCTS, INC. 0000902664-21-000330 005-88691 21537718 34 73242
2021-01-08 SC 13D SC 13D 0001193125-21-005348 005-88691 21518403 34 58155
2021-01-06 8-K 8-K 1.01,3.01,3.02,5.02,7.01,8.01,9.01 0001564590-21-000316 001-36747 21508946 34 12199996
2021-01-06 DEFA14A 8-K 0001564590-21-000317 001-36747 21508942 34 12199467
2021-01-05 SC 13G/A SABBY 13G-A EYES 1.05.21 0001535610-21-000034 005-88691 21506911 34 13119
2020-12-16 8-K 8-K 8.01 0001564590-20-057207 001-36747 201391254 34 23881
2020-12-11 8-K 8-K 1.01,9.01 0001564590-20-056762 001-36747 201381644 34 63009
2020-11-12 10-Q 10-Q 0001564590-20-053625 001-36747 201307780 34 6471029 1
2020-10-02 8-K 8-K 3.01 0001564590-20-045770 001-36747 201221354 34 27184
2020-09-30 3 FORM 3 SUBMISSION 0001209191-20-052473 3542
2020-09-29 8-K 8-K 5.02,9.01 0001564590-20-044854 001-36747 201205944 34 82998
2020-09-25 8-K 8-K 8.01,9.01 0001564590-20-044565 001-36747 201196725 34 38504
2020-09-14 3 FORM 3 SUBMISSION 0001209191-20-050252 9846
2020-09-04 8-K 8-K 5.02 0001564590-20-042660 001-36747 201162131 34 21468
2020-08-13 10-Q 10-Q 0001564590-20-040021 001-36747 201099418 34 6346566 1
2020-07-27 8-K 8-K 3.01 0001564590-20-033581 001-36747 201050661 34 26343
2020-07-22 8-K 8-K 3.01 0001564590-20-033025 001-36747 201041307 34 24677
2020-07-21 8-K 8-K 3.01 0001564590-20-032826 001-36747 201037280 34 31924
2020-07-10 8-K 8-K 1.01 0001564590-20-032187 001-36747 201023165 34 21990
2020-07-01 8-K 8-K 8.01 0001564590-20-031496 001-36747 201005354 34 22191
2020-06-26 10-Q 10-Q 0001564590-20-030851 001-36747 20994780 34 5497209 1
2020-06-04 8-K 8-K 3.01 0001564590-20-028279 001-36747 20941849 34 32205
2020-05-28 8-K 8-K 5.02 0001564590-20-027115 001-36747 20916835 34 22528
2020-05-21 8-K 8-K 1.02,9.01 0001564590-20-026553 001-36747 20901983 34 89432
2020-05-19 4 FORM 4 SUBMISSION 0001209191-20-030770 4766
2020-05-19 8-K 8-K 5.02,9.01 0001564590-20-026062 001-36747 20891528 34 37443
2020-05-12 8-K 8-K 5.02,8.01 0001564590-20-024466 001-36747 20866945 34 26951
2020-05-08 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-20-004555 005-88691 20859496 34 96099
2020-05-06 8-K 8-K 1.01,9.01 0001564590-20-021837 001-36747 20852340 34 727643
2020-05-05 8-K 8-K 8.01,9.01 0001564590-20-021143 001-36747 20848040 34 37413
2020-05-05 SC 13G SECOND SIGHT MEDICAL PRODUCTS, INC. 0000902664-20-001972 005-88691 20847142 34 88687
2020-05-01 424B5 424B5 0000950123-20-003746 333-221228 20838566 33 974855
2020-05-01 SC 13G SABBY 13G EYES 5.01.20 0001535610-20-000092 005-88691 20838550 34 13274
2020-05-01 8-K 8-K 8.01,9.01 0001564590-20-020350 001-36747 20838171 34 45763
2020-04-29 FWP FWP 0001564590-20-019393 333-198073 20827159 34 1345780
2020-04-29 424B5 424B5 0001564590-20-019389 333-221228 20827146 33 976500
2020-04-28 8-K 8-K 8.01,9.01 0001564590-20-018998 001-36747 20822404 34 62923
2020-04-28 10-K/A 10-K/A 0001564590-20-018994 001-36747 20822389 34 536899
2020-04-27 424B5 424B5 0001564590-20-018878 333-221228 20821243 33 13850
2020-04-21 8-K 8-K 3.01,5.02,8.01 0001564590-20-017705 001-36747 20805498 34 38054
2020-03-30 8-K 8-K 5.02,8.01,9.01 0001564590-20-014147 001-36747 20756793 34 53555
2020-03-19 10-K 10-K 0001564590-20-011809 001-36747 20728930 34 9450012 1
2020-03-19 8-K 8-K 2.02,7.01,9.01 0001564590-20-011798 001-36747 20728709 34 293080
2020-03-19 S-8 S-8 0001564590-20-011659 333-237266 20725974 33 201568
2020-03-12 8-K 8-K 5.02,9.01 0001564590-20-010500 001-36747 20709285 34 73268
2020-02-21 4 FORM 4 SUBMISSION 0001209191-20-011662 8974
2020-02-21 4 FORM 4 SUBMISSION 0001209191-20-011659 8827
2020-02-21 4 FORM 4 SUBMISSION 0001209191-20-011655 8850
2020-02-14 8-K 8-K 5.02 0001564590-20-004801 001-36747 20619139 34 33893

Latest XBRL company facts

One latest value per concept from companyfacts (382 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 90.20M 2026-11-12 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
dei EntityPublicFloat Entity Public Float USD 45.90M 2025-06-30 2025 FY 10-K 2026-03-26 0001753926-26-000548
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 772,134 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001753926-26-000750
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 750,927 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001753926-26-000750
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 144.76 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001753926-26-000750
invest InvestmentOptionsExercisePrice Investment Options, Exercise Price USD 11.25 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.21M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 757,000 2017-09-30 2017 Q3 10-Q 2017-11-06 0001615774-17-006224
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 455,000 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 77,000 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 32,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 182.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 20,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 378,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 20,000 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap AdvancesFairValueDisclosure Advances, Fair Value Disclosure USD 8.00M 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 117,000 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 89,000 2017-09-30 2017 Q3 10-Q 2017-11-06 0001615774-17-006224
us-gaap AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) USD 1,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 65,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 5.08M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 15.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 700,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap Assets Assets USD 35.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AssetsCurrent Assets, Current USD 15.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap AssetsFairValueAdjustment Assets, Fair Value Adjustment USD 8.00M 2022-08-28 2022-08-30 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 400,000 2020-06-30 2020 Q2 10-Q 2020-08-13 0001564590-20-040021
us-gaap AssetsNet Net Assets USD 53.30M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001753926-23-001474
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 700,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 8.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap BusinessCombinationConsiderationTransferredLiabilitiesIncurred Business Combination, Consideration Transferred, Liabilities Incurred USD 2.11M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap BusinessCombinationConsiderationTransferredOther1 Business Combination, Consideration Transferred, Other USD 8.00M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 53.26M 2022-08-30 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest USD -53.26M 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1 Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value USD 54.40M 2022-08-30 2022-09-30 2022 Q3 10-Q 2022-11-14 0001753926-22-001464
us-gaap Cash Cash USD 5.01M 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 14.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 13.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 20.69M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-06 0001564590-19-029449
us-gaap CashAvailableForDistributions Cash Available for Distributions USD 55.40M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001753926-23-001474
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 19.69M 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 15.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 45.08M 2022-12-31 2022 FY 10-K 2023-03-31 0001753926-23-000344
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 3.15 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 9.34M 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 927,152 2015-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 10,125 2020-05-05 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 44,482 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2023-07-06 2025 Q3 10-Q 2025-11-13 0001753926-25-001770
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 90.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 76.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CommonStockValue Common Stock, Value, Issued USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap CommonUnitIssuanceValue Common Unit, Issuance Value USD 280 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap CompensatedAbsencesLiability Compensated Absences Liability USD 1,696 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -20.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 976 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap ConstructionAndDevelopmentCosts Construction and Development Costs (Deprecated 2018-01-31) USD 3.00M 2010-04-01 2010-04-30 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 19,000 2025-03-31 2025 Q1 10-Q 2025-05-13 0001753926-25-000794
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 335,000 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -219,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 6.64M 2014-10-01 2014-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 5.20M 2014-06-01 2014-06-30 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 29.50M 2013-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 23.40M 2013-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 130,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 668,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap CostOfRevenue Cost of Revenue USD 912 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -144,000 2018-12-31 2020 Q2 10-Q 2020-08-13 0001564590-20-040021
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 29.50M 2013-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 6.60M 2013-01-01 2013-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap DebtCurrent Debt, Current USD 2.20M 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 5 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.075 2013-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 7.00M 2014-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 600,000 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053625
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.14M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 48,000 2017-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap DeferredRevenueLeasesAccumulatedAmortization Deferred Lease Income, Accumulated Amortization USD 200,000 2023-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 6.72M 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 6.72M 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 77.97M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 9.26M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 81,000 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 254.08M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 206.73M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 47.35M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 454,000 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap DeferredTaxAssetsRegulatoryAssetsAndLiabilities Deferred Tax Assets, Regulatory Assets and Liabilities USD 455,000 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 167.59M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 2.50M 2023-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 7.50M 2023-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 2.41M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 9.05M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 4.43M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 493,000 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 75.83M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates Deferred Tax Liabilities, Investment in Noncontrolled Affiliates USD 1.92M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 216,000 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DefinedBenefitPlanBenefitObligationBenefitsPaid Defined Benefit Plan, Benefit Obligation, Benefits Paid USD 10,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap DefinedBenefitPlanBenefitsPaid Defined Benefit Plan, Benefits Paid (Deprecated 2017-01-31) USD 132,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap DepositAssets Deposit Assets USD 200,000 2018-12-31 2019 FY 10-K 2020-03-19 0001564590-20-011809
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 50 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap Depreciation Depreciation USD 387,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 387,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 130,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001753926-26-000852
us-gaap DerivativeAverageVariableInterestRate Derivative, Average Variable Interest Rate pure 0.05 2023-08-25 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.27 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.182 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure 0.022 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.07 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.371 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0.017 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 2,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 319,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 2.10M 2023-09-30 2023 Q3 10-Q 2023-11-13 0001753926-23-001474
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.995 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap EstimateOfCancellations Estimate of Cancellations USD 20.75M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001753926-23-001474
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.499 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.016 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 9.64M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 43,000 2022-03-31 2022 Q1 10-Q 2022-05-16 0001753926-22-000721
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 151,000 2022-08-30 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 45,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -2,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap GainLossOnRepurchaseOfDebtInstrument Gain (Loss) on Repurchase of Debt Instrument USD 6.88M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001753926-23-000344
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -60,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-19 0001564590-20-011809
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 637,000 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001753926-22-001464
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap GrossProfit Gross Profit USD 130,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 34,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001753926-25-001770
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -24.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -26.61M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -1.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 4.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 357,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -5.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount USD -311,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 12,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxReconciliationTaxContingenciesOther Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Amount USD 392,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -384,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD -23.49M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -461,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 324,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 169,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -104,000 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-08 0001437749-18-019916
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -529,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -163,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 1.50M 2014-01-01 2014-11-18 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap InterestExpenseSubordinatedNotesAndDebentures Interest Expense, Subordinated Notes and Debentures USD 1.96M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 5 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap InterestIncomeOperating Interest Income, Operating USD 475,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001753926-23-000344
us-gaap InterestReceivable Interest Receivable USD 135,000 2021-06-30 2021 Q2 10-Q 2021-08-13 0001753926-21-000363
us-gaap InventoryAdjustments Inventory Adjustments USD 295,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027142
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 295,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027142
us-gaap InventoryGross Inventory, Gross USD 295,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027142
us-gaap InventoryLIFOReserveEffectOnIncomeNet Inventory, LIFO Reserve, Effect on Income, Net USD -793,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053625
us-gaap InventoryNet Inventory, Net USD 1.03M 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross USD 803,000 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 1.72M 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 9.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 179,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap LeaseCost Lease, Cost USD 20.37M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.1 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 23.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 9.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.25M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.16M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 815,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap Liabilities Liabilities USD 22.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 35.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LiabilitiesCurrent Liabilities, Current USD 6.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 3.91M 2022-08-30 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap LiabilitiesOtherThanLongtermDebtNoncurrent Liabilities, Other than Long-term Debt, Noncurrent USD 15.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LiabilitiesSubjectToCompromiseEarlyContractTerminationFees Liabilities Subject to Compromise, Early Contract Termination Fees USD 150,000 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 93,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 1.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LitigationReserveNoncurrent Estimated Litigation Liability, Noncurrent USD 1.68M 2023-03-31 2023 Q1 10-Q 2023-05-15 0001753926-23-000655
us-gaap LoansAndLeasesReceivableNetReportedAmount Loans and Leases Receivable, Net Amount USD 0 2017-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.016 2015-12-23 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap LossContingencyDamagesPaidValue Loss Contingency, Damages Paid, Value USD 1.00M 2021-05-18 2021-05-19 2025 Q3 10-Q 2025-11-13 0001753926-25-001770
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 1.63M 2024-01-26 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 1.68M 2022-01-01 2022-12-31 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap MarketableSecurities Marketable Securities USD 2.50M 2020-07-23 2020 Q3 10-Q 2020-11-12 0001564590-20-053625
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 500,000 2020-07-23 2020 Q3 10-Q 2020-11-12 0001564590-20-053625
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 7.24M 2017-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 16.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -18.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -12.55M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-07 0001615774-17-004106
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -20.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap NumberOfOperatingSegments Number of Operating Segments SEGMENT 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap NumberOfReportableSegments Number of Reportable Segments SEGMENT 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingExpenses Operating Expenses USD 21.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -21.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 3.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 17.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 15.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeasePayments Operating Lease, Payments USD 30.02M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 15.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 74,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.89M 2018-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 884,000 2018-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 158,000 2017-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 158,000 2018-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 937,000 2018-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 910,000 2018-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 158,000 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 858,000 2017-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 146,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001753926-21-000697
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.084 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 65.35M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 6.25M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap OriginationOfNotesReceivableFromRelatedParties Origination of Notes Receivable from Related Parties USD 2.00M 2023-08-23 2023-08-25 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap OtherAssetsFairValueDisclosure Other Assets, Fair Value Disclosure USD 56,000 2022-08-30 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 892,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OtherCommitment Other Commitment USD 1,623 2019-12-31 2019 FY 10-K 2020-03-19 0001564590-20-011809
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent USD 53 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 2,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 99,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -92,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax USD -117,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -7.52M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001615774-17-002130
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax USD 6.90M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap OtherExpenses Other Expenses USD 500,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OtherGeneralExpense Other General Expense USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -82,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 4 2015-01-01 2015-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -953,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 953,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 18.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap OtherShortTermInvestments Other Short-term Investments USD 7.24M 2017-12-31 2017 FY 10-K 2018-03-20 0001615774-18-002008
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD -5,941 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap PaymentsForRent Payments for Rent USD 17,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 123,684 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-15 0001615774-15-001042
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 28,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 124 2015-01-01 2015-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 48,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-13 0001753926-23-001474
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2023-06-30 2023 Q2 10-Q 2023-08-14 0001753926-23-001062
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2015-09-30 2015 Q3 10-Q 2015-11-16 0001615774-15-003266
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 937,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 1.66M 2022-08-30 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap ProceedsFromCollectionOfNotesReceivable Proceeds from Collection of Notes Receivable USD 2,000 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-08 0001437749-18-019916
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 19.69M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-08 0001437749-18-019916
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 25.94M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 9.10M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 19.52M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap ProceedsFromRepaymentsOfDebt Proceeds from (Repayments of) Debt USD -2.20M 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -54,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 123,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 238,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053625
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 50,000 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ProductWarrantyAccrualAdditionsFromBusinessAcquisition Standard and Extended Product Warranty Accrual, Additions from Business Acquisition USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-13 0001753926-21-000363
us-gaap ProductWarrantyAccrualPayments Standard and Extended Product Warranty Accrual, Decrease for Payments USD 875,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap ProductWarrantyAccrualPeriodIncreaseDecrease Standard and Extended Product Warranty Accrual, Period Increase (Decrease) USD -7,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001753926-21-000697
us-gaap PropertyPlantAndEquipmentFairValueDisclosure Property, Plant, and Equipment, Fair Value Disclosure USD 99,000 2022-08-30 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 107,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-19 0001564590-20-011809
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 3 2016-03-31 2016 Q1 10-Q 2016-05-06 0001615774-16-005226
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 12,000 2026-03-31 2026 Q1 10-Q 2026-05-13 0001753926-26-000852
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 200,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 1.50M 2023-08-23 2023-08-25 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap RepaymentsOfDebt Repayments of Debt USD 2.20M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-13 0001753926-21-000363
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 2.20M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001753926-21-000697
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 13.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 200,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 1.30M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.34M 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.34M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap RestructuringCharges Restructuring Charges USD 2.23M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 1.21M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -168.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap Revenues Revenues USD 4.00M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 976,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 701,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap SensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesImpactOfOtherThan10Or20PercentAdverseChangeInPrepaymentSpeedPercent Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets, Impact of Other than 10 or 20 Percent Adverse Change in Prepayment Speed, Percent pure 1 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap SeveranceCosts1 Severance Costs USD 1.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.063 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001615774-15-003266
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 3.72 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.022 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee shares 59,014 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 46 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 61 2019-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 77,031 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3.39M 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 155 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 17.39 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 2 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001753926-22-000721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 4.31 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001753926-22-000721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.24 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 5.92 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 5.92 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 180 2022-03-31 2022 Q1 10-Q 2022-05-16 0001753926-22-000721
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price USD/shares 15.47 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 40 2021-12-31 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 180 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 6.13B 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 5.92 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.85 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001753926-22-000721
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 6.81M 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 1.24 2023-09-30 2023 Q3 10-Q 2023-11-13 0001753926-23-001474
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 1.9 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net USD 3.00M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053625
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 48,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001564590-20-053625
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 2,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 13.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 3.53M 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 8 2020-01-05 2020-01-06 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap StockIssued1 Stock Issued USD 20,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 223,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-19 0001564590-19-008372
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 5,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001615774-18-003891
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 19.50M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-11 0001615774-16-004462
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 33.20M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 484,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-16 0001564590-21-013636
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 13.69M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0001753926-24-000959
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.10M 2021-07-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001753926-22-001464
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 16,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 54.38M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 123,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 270,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap SubordinatedBorrowingInterestRate Subordinated Borrowing, Interest Rate pure 0.1 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.31M 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 299,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 24,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001753926-25-000527
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001753926-26-000548
us-gaap UtilitiesOperatingExpenseMaintenance Utilities Operating Expense, Maintenance USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap UtilitiesOperatingExpenseOperations Utilities Operating Expense, Operations USD 2.10M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001753926-24-000616
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 1.04B 2016-12-31 2016 FY 10-K 2017-03-16 0001615774-17-001057
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 86.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106
us-gaap WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted Weighted Average Number of Limited Partnership and General Partnership Unit Outstanding, Basic and Diluted shares 39,409 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-12 0001753926-22-001055
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 32.82M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-29 0001753926-22-000356
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 86.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001753926-26-002106

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →